Skandinaviska Enskilda Banken (SEB)
BIVV

Skandinaviska Enskilda Banken (SEB)’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-45,857
Closed -$2.47M – 735
2017
Q4 		$2.47M Buy
45,857
+1,000
+2% +$54.7K 0.02% 396
2017
Q3 		$2.56M Hold
44,857
– – 0.02% 409
2017
Q2 		$2.7M Buy
44,857
+38,600
+617% +$2.2M 0.03% 403
2017
Q1 		$341K Buy
+6,257
New +$308K ﹤0.01% 687

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s BIVV Position: Q1 2018 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 45,857 shares — an estimated $2.47M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $2.7M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 45,857 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $2.47M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Bioverativ Inc. Common Stock position peaked at $2.7M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2018, filed 30 Apr 2018.